Colt CZ Group: Why I Am Upgrading This Arms Stock To Buy
2025-01-20 05:21:28 ET
Summary
- Colt CZ Group's stock has underperformed the S&P 500 but shows potential upside due to strategic acquisitions and expected 27% annual EBITDA growth.
- The company faces risks from potential shareholder dilution, currency exchange impacts, and regulatory changes affecting sales in the commercial market.
- Despite a 51% revenue increase driven by acquisitions, Colt CZ Group's lack of organic growth metrics complicates meaningful earnings analysis.
- Upgrading Colt CZ Group to a buy with a $33.27 price target, recognizing both its growth potential and associated risks.
I covered Colt CZ Group (CZGZF) in September 2024, and I was not particularly impressed by the investment case for the company. Since then, the OTC listing has lost 1.7% of its value while the S&P 500 gained more than 9%. COLTCZ which is the listing on the Prague Stock Exchange, gained 5.6% over the same time frame. However, due to currency effects, the dollar-denominated stock price decreased and that is something to keep in mind. In this report, I will be assessing whether the investment case for Colt CZ Group became more attractive by updating the risk assessment, discussing the most recent earnings and updating my price target for the stock....
Read the full article on Seeking Alpha
For further details see:
Colt CZ Group: Why I Am Upgrading This Arms Stock To BuyNASDAQ: CZGZF
CZGZF Trading
-3.19% G/L:
$43.85 Last:
175 Volume:
$43.85 Open:



